Mazus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Revenue 520.00%
(FY 2021)
- Profit -173.43%
(FY 2021)
- Ebitda -173.43%
(FY 2021)
- Net Worth -38.87%
(FY 2021)
- Total Assets 96.71%
(FY 2021)
About Mazus Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Umesh Kumar and Pushkar Prasun serve as directors at the Company.
- CIN/LLPIN
U51909PN2018PTC179611
- Company No.
179611
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Oct 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mazus Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Kumar  | Director | 15-Oct-2018 | Current |
| Pushkar Prasun | Director | 15-Oct-2018 | Current |
Financial Performance of Mazus Pharmaceuticals.
Mazus Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 520% increase. The company also saw a substantial fall in profitability, with a 173.43% decrease in profit. The company's net worth observed a substantial decline by a decrease of 38.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mazus Pharmaceuticals?
In 2021, Mazus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mazus Pharmaceuticals?
Unlock and access historical data on people associated with Mazus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mazus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mazus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
